234 related articles for article (PubMed ID: 28853293)
1. Predictors of Vasopressin Responsiveness in Critically Ill Adults.
Allen B; Kram B; Kram S; Schultheis J; Wolf S; Gilstrap D; Shapiro M
Ann Pharmacother; 2018 Feb; 52(2):126-132. PubMed ID: 28853293
[TBL] [Abstract][Full Text] [Related]
2. Mortality, Morbidity, and Costs After Implementation of a Vasopressin Guideline in Medical Intensive Care Patients With Septic Shock: An Interrupted Time Series Analysis.
Bauer SR; Sacha GL; Reddy AJ
Ann Pharmacother; 2020 Apr; 54(4):314-321. PubMed ID: 31679395
[No Abstract] [Full Text] [Related]
3. Effects of continuous vasopressin infusion in patients with septic shock.
Obritsch MD; Jung R; Fish DN; MacLaren R
Ann Pharmacother; 2004; 38(7-8):1117-22. PubMed ID: 15178740
[TBL] [Abstract][Full Text] [Related]
4. Influence of Timing and Catecholamine Requirements on Vasopressin Responsiveness in Critically ill Patients with Septic Shock.
Jakowenko ND; Murata J; Kopp BJ; Erstad BL
J Intensive Care Med; 2022 Nov; 37(11):1512-1519. PubMed ID: 35195486
[No Abstract] [Full Text] [Related]
5. The role of vasopressin and the vasopressin type V1a receptor agonist selepressin in septic shock.
Saad AF; Maybauer MO
J Crit Care; 2017 Aug; 40():41-45. PubMed ID: 28319910
[TBL] [Abstract][Full Text] [Related]
6. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Bauer SR; Lam SW; Cha SS; Oyen LJ
J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.
Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW
Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
Hammond DA; Cullen J; Painter JT; McCain K; Clem OA; Brotherton AL; Chopra D; Meena N
J Intensive Care Med; 2019; 34(11-12):910-916. PubMed ID: 28820036
[TBL] [Abstract][Full Text] [Related]
9. The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial.
Cioccari L; Luethi N; Bailey M; Shehabi Y; Howe B; Messmer AS; Proimos HK; Peck L; Young H; Eastwood GM; Merz TM; Takala J; Jakob SM; Bellomo R;
Crit Care; 2020 Jul; 24(1):441. PubMed ID: 32678054
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
[TBL] [Abstract][Full Text] [Related]
11. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
Hodge EK; Hughes DW; Attridge RL
Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
Haan BJ; Cadiz ML; Natavio AM
Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
[No Abstract] [Full Text] [Related]
13. Role of vasopressin in the management of septic shock.
Mutlu GM; Factor P
Intensive Care Med; 2004 Jul; 30(7):1276-91. PubMed ID: 15103461
[TBL] [Abstract][Full Text] [Related]
14. Vasopressin Response and Clinical Trajectory in Septic Shock Patients.
Bauer SR; Sacha GL; Siuba MT; Wang L; Wang X; Scheraga RG; Vachharajani V
J Intensive Care Med; 2023 Mar; 38(3):273-279. PubMed ID: 36062611
[TBL] [Abstract][Full Text] [Related]
15. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
Lupei MI; Beilman GJ; Chipman JG; Mann HJ
Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
[TBL] [Abstract][Full Text] [Related]
16. Machine learning to predict vasopressin responsiveness in patients with septic shock.
Scheibner A; Betthauser KD; Bewley AF; Juang P; Lizza B; Micek S; Lyons PG
Pharmacotherapy; 2022 Jun; 42(6):460-471. PubMed ID: 35426141
[TBL] [Abstract][Full Text] [Related]
17. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.
Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N
J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Vasopressin Use for Adults with Septic Shock.
Vail EA; Gershengorn HB; Hua M; Walkey AJ; Wunsch H
Ann Am Thorac Soc; 2016 Oct; 13(10):1760-1767. PubMed ID: 27404213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
